News
ALGS
5.46
-1.89%
-0.11
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 3d ago
Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 3d ago
Weekly Report: what happened at ALGS last week (0914-0918)?
Weekly Report · 3d ago
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Aligos Therapeutics Amends Long-Term Headquarters Lease Agreement
TipRanks · 09/15 20:37
Weekly Report: what happened at ALGS last week (0907-0911)?
Weekly Report · 09/14 09:33
Weekly Report: what happened at ALGS last week (0831-0904)?
Weekly Report · 09/07 09:31
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 09/02 12:07
Weekly Report: what happened at ALGS last week (0824-0828)?
Weekly Report · 08/31 09:33
Weekly Report: what happened at ALGS last week (0817-0821)?
Weekly Report · 08/24 09:34
Aligos Advances Hepatitis B Program With Completed Phase 1 Kidney Impairment Study
TipRanks · 08/21 16:31
Aligos Hepatitis B Trial Completion: What Phase 1 Liver Data Mean for ALGS Investors
TipRanks · 08/21 16:31
Weekly Report: what happened at ALGS last week (0810-0814)?
Weekly Report · 08/17 09:34
Aligos Therapeutics Initiates Dosing In Phase 1 Study Of ALG-170675, Investigational Next-Gen Antisense Oligonucleotide Being Evaluated For Functional Cure In Treatment Of Chronic HBV Infection
Benzinga · 08/12 20:24
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 08/10 17:06
Aligos Therapeutics Jumps 28% As Pevifoscorvir Advances Toward 2027 Phase 2 Data
NASDAQ · 08/10 15:41
Analysts Offer Insights on Healthcare Companies: Aligos Therapeutics (ALGS), aTyr Pharma (ATYR) and Prime Medicine, Inc. (PRME)
TipRanks · 08/10 10:30
Weekly Report: what happened at ALGS last week (0803-0807)?
Weekly Report · 08/10 09:32
Piper Sandler Sticks to Their Buy Rating for Aligos Therapeutics (ALGS)
TipRanks · 08/07 15:27
Aligos Therapeutics reports Q2 EPS (14c), consensus ($1.38)
TipRanks · 08/06 13:21
More
Webull provides a variety of real-time ALGS stock news. You can receive the latest news about Aligos Therapeutics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics to address unmet medical needs in liver diseases and viral infections, including in the areas of chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), and coronavirus infections such as, SARS-Co-V2, SARS-CoV, MERS-CoV, and other related infections. Its pipeline of drug candidates includes ALG-000184 for chronic HBV infection, ALG-055009 for MASH, ALG-097558 for coronavirus infections, and a portfolio of preclinical programs. ALG-000184 is a potential Capsid Assembly Modulator (CAM-E) for chronic HBV infection with enhanced pharmacologic properties. In the area of chronic HBV infection, its advanced drug candidate, ALG-000184, helps in disrupting the HBV lifecycle with viral suppression as well as reductions in viral antigens. Its ALG-055009 is an oral, small-molecule thyroid receptor beta agonist (THR-β) for the treatment of MASH.